Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience

  • 0Department of Health Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.

|

|

Summary

This summary is machine-generated.

Predicting liver cirrhosis complications is key. The Child-Pugh score is best for general complications, while the Model for End-Stage Liver Disease (MELD) score excels for hepato-renal syndrome. Platelet distribution width (PDW) and RDW-to-platelet ratio (RPR) show promise for varices.

Area Of Science

  • Hepatology
  • Internal Medicine
  • Clinical Diagnostics

Background

  • Liver cirrhosis involves progressive fibrosis and architectural distortion, leading to impaired function and severe complications.
  • Accurate prediction of these complications is vital for improving patient outcomes in cirrhotic patients.

Purpose Of The Study

  • To evaluate the accuracy of non-invasive biomarkers and clinical scores in assessing the risk of complications in cirrhotic patients.
  • To compare the predictive capabilities of various indices for specific complications like varices and hepato-renal syndrome.

Main Methods

  • An observational retrospective study of 236 cirrhotic patients from two tertiary care hospitals.
  • Collection and analysis of clinical data, liver function tests, hematological indices, non-invasive biomarkers, and clinical scores.
  • Receiver operating characteristic (ROC) analysis to assess predictive accuracy for complications.

Main Results

  • The Child-Pugh score demonstrated the highest accuracy for overall cirrhosis complications (AUC = 0.667), with high specificity but low sensitivity.
  • For hepato-renal syndrome, the Model for End-Stage Liver Disease (MELD) score showed the highest diagnostic accuracy (AUC = 0.758).
  • Platelet distribution width (PDW) and RDW-to-platelet ratio (RPR) exhibited modest predictive ability for varices (AUC = 0.594).

Conclusions

  • Child-Pugh score, PDW/RPR, and MELD score are the most reliable for detecting general complications, varices, and hepato-renal syndrome, respectively.
  • The moderate accuracy of some indices highlights the need for an integrated approach to risk stratification in cirrhotic patients.
  • Future research should validate these tools across diverse populations and explore emerging biomarkers for enhanced predictive accuracy.

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan 01:25

78

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT 01:25

3

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers 01:20

103

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers 01:19

59

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...